Lyumjev market outlook points to rapid growth through 2035

The Business Research Company says the global Lyumjev market is expanding as diabetes rates rise, sedentary lifestyles spread and healthcare spending climbs. North America led the market in 2025, while the report points to stronger demand for fast-acting insulin, digital glucose monitoring and home-based diabetes care.

Why it matters: - The Lyumjev market is tied to the growing need for faster diabetes treatment options as more people live with diabetes worldwide. - Demand for rapid-acting insulin matters because Lyumjev is designed to help reduce post-meal blood sugar spikes and improve glucose control. - The market outlook is also shaped by the wider shift toward digital monitoring, personalized care and home-based diabetes management.

What happened: - The Business Research Company published the Lyumjev Global Market Report 2026, covering market size, trends and forecasts for 2026-2035. - The report says the Lyumjev market is gaining momentum on rising diabetes prevalence and greater adoption of innovative therapies. - The report identifies North America as the largest regional market in 2025. - The report also covers Asia-Pacific, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The report includes market attractiveness scoring, total addressable market analysis, company scoring matrix graphics and tables, Excel-based dashboards, market hotspots infographics, and updated technology and future-trend analysis. - A free sample of the report is available here. - The full report is available here.

The details: - Lyumjev is a rapid-acting insulin formulation used to help people with diabetes regulate blood sugar. - Lyumjev works by enabling swift absorption of insulin lispro, which supports glucose uptake into cells and suppresses glucose production by the liver. - Lyumjev is designed to improve control of blood sugar spikes after meals. - Historical growth in the market has been driven by rising diabetes prevalence, demand for fast-acting insulin options, improved insulin delivery mechanisms, broader acceptance of insulin analogs and more outpatient diabetes care. - Future growth drivers include personalized diabetes treatment, integration with digital glucose monitoring, flexible insulin dosing, home-based care and stronger focus on patient adherence. - Forecast trends include greater use of ultra-rapid-acting insulin therapies, stronger preference for post-meal glucose control, more pre-filled insulin delivery devices, patient-focused diabetes management and faster insulin absorption profiles. - Diabetes Canada reported in February 2024 that the number of Canadians diagnosed with type 1 and type 2 diabetes reached 4,006,850 and is projected to rise to 5,300,670 by 2034. - The World Health Organization reported in June 2024 that nearly 31% of adults globally, or about 1.8 billion people, did not meet recommended physical activity levels in 2022. - The World Health Organization projects inactivity will rise to 35% by 2030. - The Centers for Medicare & Medicaid Services reported in December 2024 that U.S. healthcare spending rose 7.5% in 2023 to $4.9 trillion, or about $14,570 per person.

Between the lines: - The market case for Lyumjev is less about one product and more about the broader diabetes-care shift toward speed, convenience and tighter glucose control. - Rising inactivity and higher healthcare spending support demand from opposite sides: more patients need treatment, and more systems can pay for advanced therapies. - North America's lead suggests the region remains an early adopter of newer insulin and diabetes-management products.

What's next: - The report expects Lyumjev demand to keep building as diabetes cases rise and more patients move toward personalized and home-based care. - The market is likely to benefit if digital glucose tools and pre-filled delivery devices continue gaining adoption. - The Business Research Company says its 2026 reports now include expanded strategic intelligence, including TAM analysis and market hotspot visuals.